R&D Systems™ Recombinant Human Lymphotoxin alpha2/beta1 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Product Code	Brand	Formulation
18196710	R&D Systems™ 679-TX-010/CF	Lyophilized from a 0.2μm filtered solution in PBS.
18106540	R&D Systems™ 679-TX-010	Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.

Description

The Recombinant Human Lymphotoxin alpha2/beta1 Protein is derived from Sf 21 (baculovirus). The Recombinant Human Lymphotoxin alpha2/beta1 Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 4049
• Name: Lymphotoxin α2/β1
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Lymphotoxin protein Leu35-Leu205 (LT alpha ) & Leu54-Gly244 (LT beta ),both with an N-terminal Met & Thr41-Leu205 (LT alpha )
• Structural Form: Noncovalently-linked heterotrimer
• Recombinant: Recombinant

• Molecular Weight (g/mol): 18 kDa (LT alpha), 18.5 kDa ( LTbeta)
• Quantity: 10 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.